MONTREAL -- (MARKET WIRE) -- April 10, 2007 -- TOPIGEN Pharmaceuticals Inc., a development-stage biopharmaceutical company specializing in developing treatments for respiratory diseases, today announced it has expanded its management team with the appointments of company officers Lisa Nolan, Ph.D., and Mark Parry-Billings, Ph.D., to lead TOPIGEN’s business development initiatives and pharmaceutical development activities, respectively.
